Oncternal Therapeutics
(NASDAQ:ONCT)
$1.135
0.015[1.34%]
Last update: 1:07PM
Day High/Low1.13 - 1.18
52 Week High/Low0.69 - 2.64
Open / Close1.17 / -
Float / Outstanding48.9M / 49.4M
Vol / Avg.362.7K / 1.1M
Mkt Cap56.1M
P/E-
50d Avg. Price1.17
Div / Yield-
Payout Ratio-
EPS-0.2
Total Float48.9M

Oncternal Therapeutics (NASDAQ:ONCT), Quotes and News Summary

Oncternal Therapeutics (NASDAQ: ONCT)

Day High/Low1.13 - 1.18
52 Week High/Low0.69 - 2.64
Open / Close1.17 / -
Float / Outstanding48.9M / 49.4M
Vol / Avg.362.7K / 1.1M
Mkt Cap56.1M
P/E-
50d Avg. Price1.17
Div / Yield-
Payout Ratio-
EPS-0.2
Total Float48.9M
Sector: Health Care.Industry: Biotechnology
Oncternal Therapeutics Inc is a clinical-stage oncology company developing first-in-class, novel therapies that target a broad spectrum of cancers with a large unmet medical need. The Company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to ROR1 (Receptor-tyrosine kinase-like Orphan Receptor 1), and ONCT-216, a small molecule inhibiting the biological activity of ETS-family transcription factor oncoproteins. The Company is also developing ONCT-808, a CAR-T (chimeric antigen receptor T-cells) product candidate that targets ROR1 and ONCT-534, a dual-action androgen receptor inhibitor product candidate for the treatment of castration-resistant prostate and other androgen receptor-driven cancers.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-11-03
REV
Q2 2022Est.ActualSurprise
EPS-0.230-0.230 0.0000
REV460.000K191.000K-269.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Oncternal Therapeutics Questions & Answers

Q
How do I buy Oncternal Therapeutics (ONCT) stock?
A

You can purchase shares of Oncternal Therapeutics (NASDAQ: ONCT) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Oncternal Therapeutics's (ONCT) competitors?
Q
What is the target price for Oncternal Therapeutics (ONCT) stock?
A

The latest price target for Oncternal Therapeutics (NASDAQ: ONCT) was reported by HC Wainwright & Co. on Wednesday, August 10, 2022. The analyst firm set a price target for 7.00 expecting ONCT to rise to within 12 months (a possible 516.74% upside). 3 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Oncternal Therapeutics (ONCT)?
A

The stock price for Oncternal Therapeutics (NASDAQ: ONCT) is $1.135 last updated Today at August 11, 2022, 5:07 PM UTC.

Q
Does Oncternal Therapeutics (ONCT) pay a dividend?
A

There are no upcoming dividends for Oncternal Therapeutics.

Q
When is Oncternal Therapeutics (NASDAQ:ONCT) reporting earnings?
A

Oncternal Therapeutics’s Q3 earnings are confirmed for Thursday, November 3, 2022.

Q
Is Oncternal Therapeutics (ONCT) going to split?
A

There is no upcoming split for Oncternal Therapeutics.

Q
What sector and industry does Oncternal Therapeutics (ONCT) operate in?
A

Oncternal Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.